Tiburcio, Taynã Cristina; Willebrords, Joost; Silva, Tereza Cristina da; Pereira, Isabel Veloso Alves; Nogueira, Marina Sayuri; Yanguas, Sara Crespo; Maes, Michaël; Silva, Elisangela dos Anjos; Dagli, Maria Lúcia Zaidan; Castro, Inar Alves de 
; Oliveira, Cláudia Pinto Marques Souza de; Vinken, Mathieu; Cogliati, Bruno
Source: Clinical and Experimental Pharmacology and Physiology. Unidades: FMVZ, FCF, FM
Subjects: CONEXINAS, HEPATOPATIAS, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIBURCIO, Taynã Cristina et al. Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis. Clinical and Experimental Pharmacology and Physiology, v. 44, n. 2, p. 197-206, 2017Tradução . . Disponível em: https://doi.org/10.1111/1440-1681.12701. Acesso em: 27 abr. 2024.APA
Tiburcio, T. C., Willebrords, J., Silva, T. C. da, Pereira, I. V. A., Nogueira, M. S., Yanguas, S. C., et al. (2017). Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis. Clinical and Experimental Pharmacology and Physiology, 44( 2), 197-206. doi:10.1111/1440-1681.12701NLM
Tiburcio TC, Willebrords J, Silva TC da, Pereira IVA, Nogueira MS, Yanguas SC, Maes M, Silva E dos A, Dagli MLZ, Castro IA de, Oliveira CPMS de, Vinken M, Cogliati B. Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis [Internet]. Clinical and Experimental Pharmacology and Physiology. 2017 ; 44( 2): 197-206.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1111/1440-1681.12701Vancouver
Tiburcio TC, Willebrords J, Silva TC da, Pereira IVA, Nogueira MS, Yanguas SC, Maes M, Silva E dos A, Dagli MLZ, Castro IA de, Oliveira CPMS de, Vinken M, Cogliati B. Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis [Internet]. Clinical and Experimental Pharmacology and Physiology. 2017 ; 44( 2): 197-206.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1111/1440-1681.12701
